Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01737944 · ClinicalTrials.gov registry record · Phase 1
Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration
A Phase 1 study, sponsored by Antares Pharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 38
- Enrollment target
NCT01737944 is a Phase 1 study that has completed, run by Antares Pharma. The registered enrollment target is 38 participants.
The verdict
NCT01737944, a Phase 1 study, has completed, sponsored by Antares Pharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 38 participants
- Enrollment target
Study Summary
Pharmacokinetics (PK) study
Interventions
- DRUG Methotrexate (MTX)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01737944
The ClinicalTrials.gov registry entry for NCT01737944 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Antares Pharma, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Methotrexate (MTX) is the first listed.
NCT01737944 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01737944 about?
NCT01737944 is a clinical study titled "Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration". Pharmacokinetics (PK) study
What is the current status of trial NCT01737944?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2011-01. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01737944?
The interventions under investigation include: Methotrexate (MTX) (DRUG).
Who is sponsoring clinical trial NCT01737944?
This trial is sponsored by Antares Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.